The GLP is committed to full transparency. Download and review our 2019 Annual Report

EU regulations contributing to consolidation in biotech, agrochemicals industries

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Bayer AG’s big push into the U.S. agrochemical market with its planned acquisition of Monsanto Co. could help it offset a growing problem on its home turf: increasingly stringent European regulation.

The oversight has been driven by fierce public resistance in the European Union to pesticides and
other crop-protection chemicals…

“The single biggest challenge [in the EU] is regulation on the crop protection side,” said Liam Condon, the head of Bayer’s crop science division… “It’s taking longer and longer to bring products to market.”

The regulatory environment, along with low crop prices in North America, has helped drive a wave of consolidation in the agrochemicals industry.


The Bayer-Monsanto deal would allow the two companies to pool resources to increase research and development and investment in technology… said David Zaruk, a professor at Université Saint-Louis in Brussels.

Mr. Zaruk said smaller seed and crop companies in Europe mostly have been priced out of the market and must team up with multinationals to get their products out because of the hundreds of millions of euros it can cost to comply with regulatory standards.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: Bayer’s Monsanto Purchase Could Offset European Regulatory Concerns

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend